Convertible

Hercules Capital Prices Upsized Public Offering of $350.0 Million 3.375% Notes due 2027

Retrieved on: 
Friday, January 14, 2022 - 10:33pm

Hercules Capital, Inc. (NYSE: HTGC) (Hercules or the Company), today announced that it has priced an underwritten public offering of $350.0 million in aggregate principal amount of 3.375% notes due January 2027 (the Notes).

Key Points: 
  • Hercules Capital, Inc. (NYSE: HTGC) (Hercules or the Company), today announced that it has priced an underwritten public offering of $350.0 million in aggregate principal amount of 3.375% notes due January 2027 (the Notes).
  • The closing of the transaction is subject to customary closing conditions and the Notes are expected to be delivered and paid for on January 20, 2022.
  • Goldman Sachs & Co. LLC, RBC Capital Markets, LLC, and SMBC Nikko Securities America, Inc. are acting as joint book-running managers of this offering.
  • In addition, Hercules has one retail bond issuance of 6.25% Notes due 2033 (NYSE: HCXY).

PAVmed and Lucid Diagnostics Welcome New Full-Time Investor Relations Team

Retrieved on: 
Wednesday, January 12, 2022 - 1:25pm

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (PAVmed), a diversified commercial-stage medical technology company, and its majority-owned subsidiary Lucid Diagnostics Inc. (Nasdaq: LUCD) (Lucid), a commercial-stage cancer prevention diagnostics company, today announced they have launched a new, full-time investor relations team to serve both companies.

Key Points: 
  • PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (PAVmed), a diversified commercial-stage medical technology company, and its majority-owned subsidiary Lucid Diagnostics Inc. (Nasdaq: LUCD) (Lucid), a commercial-stage cancer prevention diagnostics company, today announced they have launched a new, full-time investor relations team to serve both companies.
  • Wallace has been appointed Director, Retail Investor Relations, working closely with Mr. Miller.
  • PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors.
  • Lucid Diagnostics Inc. (Nasdaq: LUCD) is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM).

Empire Petroleum Corporation Announces Debt Retirement

Retrieved on: 
Thursday, January 6, 2022 - 1:45pm

Empire Petroleum Corporation (Empire) (OTCQB:EMPR), an operator of conventional oil and gas properties, announced today that certain debt holders have now converted 100% of their remaining debt along with accrued interest into Empire common shares.

Key Points: 
  • Empire Petroleum Corporation (Empire) (OTCQB:EMPR), an operator of conventional oil and gas properties, announced today that certain debt holders have now converted 100% of their remaining debt along with accrued interest into Empire common shares.
  • The elimination of EEFs debt removes a substantial debt liability from Empires balance sheet while also eliminating over $200K in annual interest payments.
  • "Energy Evolution Fund is an absolute supporter of Empire Petroleum Corporation and the Empire shareholders.
  • Empire Petroleum Corporation is a publicly traded, Tulsa-based oil and gas company with current producing assets in Texas, Louisiana, North Dakota, Montana and New Mexico.

La Mancha Announces Acquisition of Shares of Horizonte Minerals PLC

Retrieved on: 
Wednesday, December 22, 2021 - 11:07pm

(La Mancha), a Luxembourg-incorporated private investment company focused on opportunities primarily in the precious metals and battery metals mining sector, is pleased to announce that it has completed a subscription for 759,128,764 ordinary shares (the Ordinary Shares) of Horizonte Minerals PLC (Horizonte) (London-AIM: HZM; TSX: HZM).

Key Points: 
  • (La Mancha), a Luxembourg-incorporated private investment company focused on opportunities primarily in the precious metals and battery metals mining sector, is pleased to announce that it has completed a subscription for 759,128,764 ordinary shares (the Ordinary Shares) of Horizonte Minerals PLC (Horizonte) (London-AIM: HZM; TSX: HZM).
  • Immediately prior to the completion of the Private Placement, La Mancha did not beneficially own, directly or indirectly, or exercise control or direction over any Ordinary Shares.
  • Immediately following completion of the Private Placement, La Mancha became an insider of Horizonte, owning 759,128,764 Ordinary Shares representing approximately 19.96% of the issued and outstanding Ordinary Shares (on an undiluted basis).
  • La Mancha completed the Private Placement and agreed to acquire the Convertible Note for business and investment purposes.

Bunker Hill Announces $50 Million Project Finance Package, Mine Purchase, and US EPA Settlement Agreement Amendment

Retrieved on: 
Monday, December 20, 2021 - 10:11pm

TORONTO, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corp. (the “Company”) (CSE: BNKR; OTCQB: BHLL) is pleased to announce the achievement of its key short-term objectives, including the execution of a non-binding term sheet outlining a $50 million non-dilutive project finance package, the purchase of the Bunker Hill Mine, and the execution of a settlement agreement amendment with the US Environmental Protection Agency (“US EPA” or “EPA”). All figures in this news release are in US dollars unless otherwise stated.

Key Points: 
  • Together with the purchase of the mine and an amended settlement agreement with the EPA, a rapid restart of the prolific Bunker Hill Mine is now clearly within sight.
  • The package consists of an $8 million Royalty Convertible Debenture, a $5 million Convertible Debenture, and a multi-metals Stream of up to $37 million.
  • These proceeds will fund the purchase of the Bunker Hill Mine and near-term working capital requirements, including a $2 million payment to the EPAin January 2022 (see EPA Settlement Agreement Amendment section below).
  • The new payment schedule includes a $2 million payment to US EPA within 30 days of execution of this amendment.

Navios Maritime Holdings Inc. Announces $550 Million of Debt Financing

Retrieved on: 
Tuesday, December 14, 2021 - 1:52pm

GRAND CAYMAN, Cayman Islands, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Navios Maritime Holdings Inc. (Navios Holdings) (NYSE: NM), a global seaborne shipping and logistics company, today announced that it entered into agreements providing Navios Holdings with a total of $550 million of debt financing.

Key Points: 
  • GRAND CAYMAN, Cayman Islands, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Navios Maritime Holdings Inc. (Navios Holdings) (NYSE: NM), a global seaborne shipping and logistics company, today announced that it entered into agreements providing Navios Holdings with a total of $550 million of debt financing.
  • The proceeds of this financing together with available cash will be used to repay at maturity all of Navios Holdings outstanding 7.375% First Priority Ship Mortgage Notes (Ship Mortgage Notes) due January 15, 2022 and redeem $50.0 million of Navios Holdings outstanding 11.25% Senior Secured Notes (the Senior Secured Notes) due on August 15, 2022 (after which $105.0 million will remain outstanding).
  • Navios Holdings entered into two commercial bank facilities and four sale leaseback agreements in an aggregate principal amount of $287.0 million.
  • Navios Holdings makes no prediction or statement about the performance of its common stock or debt securities.

HEXO Reports First Quarter 2022 Results and Launches New Strategic Plan, “The Path Forward” to Solidify its Position as Canada’s Leading Cannabis Company

Retrieved on: 
Tuesday, December 14, 2021 - 12:15pm

GATINEAU, Quebec, Dec. 14, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (TSX: HEXO; NASDAQ: HEXO) (“HEXO” or the “Company”), a leading producer of high-quality cannabis products, today reported its financial results for the fiscal quarter ended October 31, 2021 (Q1’22), and announced “The Path Forward”, a new strategic plan to solidify itself as Canada’s leading cannabis company and position it to capitalize on international opportunities. The plan utilizes HEXO’s current assets, including its recent acquisitions and unique capabilities to drive accelerated growth and become cash flow positive within the next four quarters. This plan is underpinned by actions to strengthen its balance sheet, its executive team and its corporate governance.

Key Points: 
  • GATINEAU, Quebec, Dec. 14, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (TSX: HEXO; NASDAQ: HEXO) (HEXO or the Company), a leading producer of high-quality cannabis products, today reported its financial results for the fiscal quarter ended October 31, 2021 (Q122), and announced The Path Forward, a new strategic plan to solidify itself as Canadas leading cannabis company and position it to capitalize on international opportunities.
  • Total net revenue increased 29% to $50.2 million from $38.7 million in Q421, and up 70% from the comparative quarter of fiscal 2021.
  • The Companys total non-beverage gross margin before adjustments increased to 28% from 25% in the previous quarter.
  • Condensed summary of results for the three months ended October 31, 2021, July 31, 2021 and October 31, 2020.

Rapha Capital BioVentures Fund I Launches DELIVER Therapeutics Inc. with $3 Million Convertible Note Financing

Retrieved on: 
Tuesday, December 14, 2021 - 1:30pm

Rapha Capital is an investment management firm focused on making strategic investments in early stage, non-public biotechnology companies, through special purpose, joint venture entities which it manages.

Key Points: 
  • Rapha Capital is an investment management firm focused on making strategic investments in early stage, non-public biotechnology companies, through special purpose, joint venture entities which it manages.
  • About Rapha Capital Management, LLC and Rapha Capital BioVentures Fund I, LP Rapha Capital Management, LLC is an investment management firm located in Miami, Florida, focusing on strategic investments in early stage, non-public biotechnology companies.
  • Rapha Capital Management offers alternative asset management services to the RCBV Fund, which is the vehicle for all current and future investments managed by Rapha Capital Management.
  • For more information about DELIVER Therapeutics, Inc., email info@deliverthera.com or visit https://www.delivertherapeutics.com
    For more information about Rapha Capital Management, email info@raphacapital.com or visit https://www.raphacap.com
    View original content to download multimedia: https://www.prnewswire.com/news-releases/rapha-capital-bioventures-fund-...

Special Opportunities Fund, Inc. Commences Rights Offering

Retrieved on: 
Friday, December 10, 2021 - 6:25pm

The rights will expire on January 21, 2022 unless extended and will entitle the holder to purchase one share of a Convertible Preferred Stock at a price of $25.00 per share for each right held.

Key Points: 
  • The rights will expire on January 21, 2022 unless extended and will entitle the holder to purchase one share of a Convertible Preferred Stock at a price of $25.00 per share for each right held.
  • The Fund anticipates that the rights will be listed on NYSE and the new Convertible Preferred Stock will be listed on the New York Stock Exchange.
  • All holders of rights who fully subscribe in the offering will have the option to oversubscribe for additional shares of Convertible Preferred Stock which may be available if fewer than all rights are exercised.
  • A registration statement/prospectus covering the rights offering and the Convertible Preferred Shares to be issued has been filed with the Securities and Exchange Commission and is available at www.sec.gov .

Confluent Announces Proposed $1.0 Billion Offering of Convertible Senior Notes

Retrieved on: 
Wednesday, December 8, 2021 - 12:07pm

The Notes will be general unsecured obligations of Confluent and will accrue interest payable semiannually in arrears.

Key Points: 
  • The Notes will be general unsecured obligations of Confluent and will accrue interest payable semiannually in arrears.
  • The interest rate, initial conversion rate and other terms of the Notes will be determined at the time of pricing of the Offering.
  • Confluent expects to use a portion of the net proceeds from the Offering to pay the cost of the capped call transactions described below.
  • This press release contains forward-looking statements including statements concerning the proposed terms of the Notes and capped call transactions, the completion, timing and size of the proposed Offering of the Notes and capped call transactions, and the anticipated use of proceeds from the Offering.